Home > Insider Trading > Filing (0001562180-19-005222)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1434418	Constellation Pharmaceuticals Inc	CNST	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1760185	Patrick Trojer	C/O Constellation Pharmaceuticals, Inc. 215 First Street, Suite 200 Cambridge MA 02142	Chief Scientific Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-10-22	4,159	$5.62	14,436	No	4	M	Direct
Common Stock	Acquisiton	2019-10-22	820	$5.51	15,256	No	4	M	Direct
Common Stock	Acquisiton	2019-10-22	2,370	$4.08	17,626	No	4	M	Direct
Common Stock	Acquisiton	2019-10-22	581	$7.60	18,207	No	4	M	Direct
Common Stock	Disposition	2019-10-22	9,985	$15.00	8,222	No	4	S	Direct
Common Stock	Acquisiton	2019-10-23	300	$5.51	8,522	No	4	M	Direct
Common Stock	Disposition	2019-10-23	300	$15.20	8,222	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2019-10-22	581	$0.00	581	$7.60
Common Stock	Stock Option (Right to Buy)	Disposition	2019-10-22	4,159	$0.00	4,159	$5.62
Common Stock	Stock Option (Right to Buy)	Disposition	2019-10-22	820	$0.00	820	$5.51
Common Stock	Stock Option (Right to Buy)	Disposition	2019-10-22	2,370	$0.00	2,370	$4.08
Common Stock	Stock Option (Right to Buy)	Disposition	2019-10-23	300	$0.00	300	$5.51

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,689	2026-02-18	No	4	M	Direct
21,601	2025-11-08	No	4	M	Direct
26,884	2027-02-16	No	4	M	Direct
195	2022-03-06	No	4	M	Direct
26,584	2027-02-16	No	4	M	Direct

Footnotes

These trades were made pursuant to a Rule 10b5-1 trading plan.
This transaction was executed in multiple trades at prices ranging from $15.00 to $15.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $15.00 to $15.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This option was granted on February 19, 2016, and the shares underlying the options vest in equal quarterly installments through February 19, 2020.
This option was granted on November 9, 2015, and is fully vested.
This option was granted on February 17, 2017, and the shares underlying the options vest in equal quarterly installments through February 17, 2021.
This option was granted on March 7, 2012, and is fully vested.